HCMSG - Hepatitis C Mentor & Support Group, Inc.
Search
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
  • Resources
    • Corona Virus
    • Hep C Facts & Stats
    • Medications and Treatments >
      • Patient Assistance Programs
    • Reading
    • Links
  • Programs/Training
    • The Circle Model >
      • THE CIRCLE Registration
      • Group and Facilitator Guide
    • Hepatitis C Online Training
    • The Hepatitis C Education and Support Group Assistance Program
    • Healthcare Provider Training
  • Newsletter
  • Blog
  • Support Us
    • Holiday 2020
  • Contact Us

  Insurers Probed on Hepatitis C Drug Coverage 

3/3/2016

0 Comments

 
New York state’s attorney general investigates alleged restrictions on expensive but effective drugs

​By Corinne Ramey

March 2, 2016

New York’s attorney general is investigating state health-insurance companies for allegedly restricting coverage of drugs that can cure hepatitis C, saying that the firms have inappropriately rationed care by denying patients expensive but effective medication.
 
Some of the drugs have been the subject of consumer lawsuits, a continuing inquiry by the Massachusetts attorney general and a warning by federal officials that state Medicaid programs may be violating federal law by denying patients the medication. Pharmaceutical companies say the drugs are worth the cost because they result in long-term savings in care.
 
New York state Attorney General Eric Schneiderman’s office has issued subpoenas to 16 health insurers—which includes all major commercial plans in the state—requesting documents on the companies’ processes for authorizing drugs used to treat hepatitis C and documentation on patients who have been denied coverage, said a person familiar with the investigation.
 
The subpoenas began to go out last fall, and some were sent as recently as two weeks ago.

 
The inquiry centers on whether the firms are engaging in misleading and deceptive practices, because the law requires accurate disclosure of what they cover and consider medically necessary, according to Mr. Schneiderman’s office. Thousands of patients with hepatitis C may have been illegally denied coverage, according to the office.
 
Representatives from Aetna Inc., CareConnect and EmblemHealth Inc. confirmed they received subpoenas but declined to comment.
 
The New York Health Plan Association, which represents health insurers, said clinical guidelines for the hepatitis C drugs were quickly evolving and plans were adapting their coverage to the new medical information that becomes available.
 
“We feel the subpoena is overly broad, and doesn’t take into consideration the impact of the excessive pricing of the drug,” an association spokeswoman said.

TO CONTINUE:  
http://www.wsj.com/articles/insurers-probed-on-hepatitis-c-drug-coverage-1456965087
​


0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011

    Categories

    All

    RSS Feed

Privacy Policy